0,862  0,002  5 Hydroxytryptamine release stimulant
0,815  0,002  FMO3 substrate
0,754  0,003  Flavin-containing monooxygenase substrate
0,742  0,001  Phenylalanine 4-hydroxylase inhibitor
0,734  0,009  GST A substrate
0,729  0,004  Psychostimulant
0,713  0,002  Tyrosine 3 hydroxylase inhibitor
0,677  0,006  UGT1A6 substrate
0,643  0,004  Peroxidase inhibitor
0,608  0,012  Stroke treatment
0,585  0,010  Ulceration
0,561  0,017  Radioprotector
0,548  0,016  Interleukin antagonist
0,520  0,019  Cytostatic
0,503  0,003  Excitatory amino acid transporter EAAC1 inhibitor
0,483  0,012  Acute neurologic disorders treatment
0,471  0,003  Histidine decarboxylase inhibitor
0,468  0,004  Antiparkinsonian, tremor relieving
0,495  0,034  5 Hydroxytryptamine release inhibitor
0,460  0,007  Antimigraine
0,484  0,034  Calcium channel L-type activator
0,471  0,030  CYP2D6 substrate
0,451  0,015  Insulysin inhibitor
0,435  0,003  Arylamine N-Acetyltransferase substrate
0,450  0,019  Superoxide dismutase inhibitor
0,465  0,052  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,421  0,013  Growth hormone agonist
0,412  0,005  GABA C receptor agonist
0,438  0,035  FMO1 substrate
0,414  0,012  5 Hydroxytryptamine uptake stimulant
0,393  0,004  Catalase inhibitor
0,442  0,054  Histamine release inhibitor
0,433  0,048  GABA C receptor rho-3 antagonist
0,385  0,005  Gastrin inhibitor
0,425  0,048  Vasodilator, peripheral
0,367  0,002  Prolactin inhibitor
0,409  0,047  Immunostimulant
0,384  0,024  Pyruvate kinase inhibitor
0,390  0,030  Interleukin 2 agonist
0,394  0,036  UGT1A9 substrate
0,361  0,003  NAT2 substrate
0,414  0,073  TNF expression inhibitor
0,337  0,002  AMPA 4 receptor antagonist
0,368  0,036  DNA damaging
0,342  0,010  Corneal wound healing stimulator
0,354  0,023  Antiparkinsonian, rigidity relieving
0,333  0,002  DOPA decarboxylase inhibitor
0,351  0,023  Septic shock treatment
0,342  0,018  DNA methylase inhibitor
0,329  0,005  Adenylate kinase inhibitor
0,369  0,048  Teratogen
0,360  0,042  Chemoprotective
0,347  0,033  Angiogenesis stimulant
0,353  0,039  Radiosensitizer
0,314  0,003  Kainate receptor antagonist
0,322  0,012  Neurotensin receptor agonist
0,316  0,007  Aminopeptidase B inhibitor
0,310  0,005  SULT1A1 substrate
0,379  0,075  Antipruritic, allergic
0,352  0,050  CYP1A2 substrate
0,355  0,058  Antihypertensive
0,359  0,061  Antithrombotic
0,320  0,024  Antihypotensive
0,316  0,021  DNA methyltransferase I inhibitor
0,298  0,003  AMPA 1 receptor antagonist
0,315  0,021  Thrombolytic
0,322  0,029  Sedative
0,368  0,074  CYP2C9 substrate
0,305  0,013  Antidiarrheal
0,351  0,059  Immunomodulator
0,297  0,009  Antiviral (West Nile virus)
0,293  0,011  Sulfotransferase substrate
0,302  0,022  Antianorexic
0,300  0,021  Lipocortins synthesis antagonist
0,362  0,084  CYP2C19 inhibitor
0,281  0,004  Argininosuccinate synthase inhibitor
0,323  0,050  Antineoplastic (endocrine cancer)
0,307  0,037  Ca2+/calmodulin-dependent kinase I alpha inhibitor
0,276  0,006  Constipation treatment
0,321  0,051  Antihypoxic
0,275  0,005  Coagulant
0,276  0,008  5 Hydroxytryptamine 3E antagonist
0,326  0,061  Analeptic
0,280  0,016  Antineoplastic antimetabolite
0,384  0,121  Caspase 9 stimulant
0,318  0,055  Embryotoxic
0,264  0,002  Kainate receptor 1 antagonist
0,267  0,008  Aminoacyl-tRNA synthetase inhibitor
0,295  0,036  Abortion inducer
0,322  0,066  Antiischemic
0,304  0,050  Antiamyloidogenic
0,255  0,002  Kainate receptor 2 antagonist
0,310  0,057  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,364  0,112  Antiarthritic
0,299  0,048  Interleukin agonist
0,258  0,009  NMDA receptor antagonist
0,372  0,123  Antineoplastic (solid tumors)
0,252  0,003  AMPA 3 receptor antagonist
0,251  0,004  5 Hydroxytryptamine 2A agonist
0,262  0,015  Carcinogenic, group 1
0,260  0,014  Glutamate receptor antagonist
0,299  0,053  Platelet antagonist
0,253  0,009  Toll-Like receptor 2 antagonist
0,248  0,004  Myeloperoxidase inhibitor
0,257  0,015  Age-related macular degeneration treatment
0,243  0,005  Carbonic anhydrase stimulant
0,247  0,010  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,298  0,062  UGT2B4 substrate
0,243  0,010  Antifungal (Cryptococcus)
0,234  0,004  NMDA 2A receptor antagonist
0,239  0,011  5 Hydroxytryptamine agonist
0,229  0,004  NMDA receptor agonist
0,245  0,021  Aldehyde oxidase substrate
0,227  0,005  GABA C receptor rho-1 antagonist
0,271  0,052  5 Hydroxytryptamine 1E antagonist
0,299  0,081  Antineoplastic (brain cancer)
0,222  0,004  Cholecystokinin antagonist
0,251  0,034  Insulin sensitizer
0,217  0,004  NMDA receptor subunit 3B antagonist
0,251  0,040  Pneumotoxic
0,316  0,105  CYP2C9 inhibitor
0,267  0,057  DNA synthesis inhibitor
0,213  0,004  AMPA 2 receptor antagonist
0,271  0,063  Vascular (periferal) disease treatment
0,217  0,009  Interleukin 8 antagonist
0,217  0,011  Contraceptive female
0,221  0,015  Retinoprotector
0,243  0,037  Nitric-oxide synthase stimulant
0,293  0,087  Antineoplastic (small cell lung cancer)
0,224  0,019  Cell adhesion inhibitor
0,217  0,012  Antispirochetal
0,209  0,004  Cholecystokinin A antagonist
0,236  0,031  Antiischemic, cerebral
0,212  0,009  Glutamate dehydrogenase inhibitor
0,204  0,004  NMDA receptor subunit 3A antagonist
0,210  0,011  GABA C receptor antagonist
0,221  0,022  Adenylate cyclase inhibitor
0,202  0,004  AMPA receptor antagonist
0,201  0,003  GABA B receptor agonist
0,215  0,018  Shock treatment
0,215  0,019  Ferrochelatase inhibitor
0,255  0,061  Calpain inhibitor
0,199  0,005  Histamine N-methyltransferase inhibitor
0,221  0,028  Pancreatic disorders treatment
0,219  0,027  Uterine stimulant
0,261  0,069  Proliferative diseases treatment
0,286  0,095  Apoptosis antagonist
0,202  0,013  Adenylate cyclase stimulant
0,249  0,062  Cytotoxic
0,200  0,014  Protein kinase C gamma inhibitor
0,214  0,027  Pulmonary hypertension treatment
0,197  0,011  5 Hydroxytryptamine 1 agonist
0,198  0,012  HIV-1 integrase (Overall Integration) inhibitor
0,279  0,095  AR expression inhibitor
0,207  0,025  GABA C receptor rho-2 antagonist
0,202  0,020  CF transmembrane conductance regulator agonist
0,242  0,060  Anticonvulsant
0,203  0,022  Cathepsin H inhibitor
0,214  0,034  Antidote
0,243  0,063  Neuropeptide Y2 antagonist
0,206  0,026  GST P1-1 substrate
0,193  0,014  Photosensitizer
0,198  0,020  Nav1.4 sodium channel blocker
0,223  0,046  Anticoagulant
0,188  0,012  Nitric-oxide synthase inhibitor
0,280  0,105  Cholesterol antagonist
0,227  0,053  Ca2+/calmodulin-dependent kinase II gamma inhibitor
0,265  0,094  NOS3 expression inhibitor
0,191  0,020  Falcipain 3 inhibitor
0,277  0,108  Transcription factor NF kappa B inhibitor
0,182  0,014  Protein kinase C zeta inhibitor
0,176  0,009  Somatostatin 1 agonist
0,173  0,006  Restless leg syndrome treatment
0,304  0,138  Antiparkinsonian
0,199  0,033  Renal failure treatment
0,216  0,051  Sepsis treatment
0,238  0,073  Cardiodepressant
0,223  0,059  UGT1A1 substrate
0,173  0,009  Glutamate decarboxylase inhibitor
0,221  0,062  Wound healing agent
0,195  0,036  Alpha-N-acetylglucosaminidase inhibitor
0,183  0,025  Antiviral (Poxvirus)
0,311  0,153  Antidiabetic
0,311  0,153  Cyclophilin D inhibitor
0,161  0,004  Glutamate (mGluR4) antagonist
0,165  0,007  Endothelin-converting enzyme inhibitor
0,262  0,106  Bone diseases treatment
0,166  0,010  Aminopeptidase I inhibitor
0,254  0,099  Respiratory analeptic
0,211  0,057  UGT2B7 substrate
0,177  0,023  5 Hydroxytryptamine 3A agonist
0,166  0,013  Inducible nitric-oxide synthase inhibitor
0,198  0,045  Phospholipase C inhibitor
0,196  0,044  Phospholipase A2 inhibitor
0,170  0,018  Heat shock protein 70 antagonist
0,216  0,064  Carcinogenic
0,155  0,004  Cholecystokinin B antagonist
0,164  0,014  NMDA 2 receptor antagonist
0,181  0,033  Antihyperlipoproteinemic
0,151  0,003  SULT2A1 substrate
0,153  0,005  Glutamate (mGluR group III) agonist
0,230  0,083  NOS2 expression inhibitor
0,193  0,047  Antirickettsial
0,184  0,037  Histone deacetylase SIRT1 inhibitor
0,156  0,010  Bombesin 2 receptor antagonist
0,163  0,018  Porphobilinogen synthase inhibitor
0,162  0,017  Triose-phosphate isomerase inhibitor
0,197  0,052  UGT1A3 substrate
0,246  0,101  Antiepileptic
0,210  0,065  UDP-glucuronosyltransferase substrate
0,161  0,018  Folate antagonist
0,195  0,052  Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor
0,150  0,007  Glycine receptor antagonist
0,171  0,029  Growth stimulant
0,173  0,032  Cystathionine beta-synthase inhibitor
0,179  0,039  Antianemic
0,163  0,023  Aldehyde dehydrogenase substrate
0,229  0,090  Aldehyde oxidase inhibitor
0,173  0,035  Antieczematic
0,266  0,128  Calcium channel activator
0,246  0,108  CYP2D6 inhibitor
0,217  0,079  Peptidyltransferase inhibitor
0,140  0,005  Cholecystokinin B agonist
0,237  0,101  CYP2C19 substrate
0,137  0,004  Glutamate (mGluR3) antagonist
0,138  0,004  Glutamate (mGluR group III) antagonist
0,142  0,011  Integrin antagonist
0,174  0,044  SULT1A3 substrate
0,155  0,027  Antiviral (Papilloma)
0,255  0,129  CYP3A4 substrate
0,218  0,093  Aryl hydrocarbon receptor agonist
0,213  0,087  Free radical scavenger
0,128  0,002  Kainate receptor agonist
0,129  0,005  Glutamate (mGluR6) antagonist
0,135  0,010  Bombesin 1 receptor agonist
0,192  0,068  VEGF expression inhibitor
0,132  0,009  NMDA 2C receptor antagonist
0,151  0,028  UGT2B1 substrate
0,132  0,011  Ornithine carbamoyltransferase inhibitor
0,134  0,013  Carbamoyl phosphate synthetase inhibitor
0,135  0,015  Antifungal (Candida)
0,142  0,021  GST T1-1 substrate
0,198  0,079  Amyloid beta aggregation inhibitor
0,163  0,045  Cachexia treatment
0,129  0,012  Toll-Like receptor 2 agonist
0,163  0,048  Movement disorders treatment
0,115  0,002  Tryptophan hydroxylase 1 inhibitor
0,151  0,038  Carcinogenic, group 2B
0,115  0,003  Glutamate (mGluR1) agonist
0,131  0,020  Cell adhesion molecule inhibitor
0,167  0,056  Thiol protease inhibitor
0,191  0,080  Ca2+/calmodulin-dependent protein kinase inhibitor
0,129  0,019  Hematopoietic
0,113  0,005  Glutamate (mGluR7) antagonist
0,141  0,034  Antineoplastic, alkylator
0,131  0,024  Paget's disease treatment
0,127  0,020  Factor XII inhibitor
0,208  0,101  Myocardial infarction treatment
0,177  0,071  Succinate dehydrogenase inhibitor
0,161  0,056  Hemostatic
0,180  0,075  Mutagenic
0,167  0,062  Melanin inhibitor
0,188  0,084  Antiviral (Ebola)
0,106  0,002  Tryptophan 5 hydroxylase inhibitor
0,124  0,020  Keratolytic
0,108  0,005  5 Hydroxytryptamine 1B agonist
0,160  0,057  Cell wall synthesis inhibitor
0,143  0,043  Glutathione S-transferase substrate
0,168  0,069  Catenin beta inhibitor
0,187  0,088  Ca2+/calmodulin-dependent kinase II beta inhibitor
0,115  0,016  Glucagon-like peptide 1 agonist
0,192  0,093  Antialcoholic
0,262  0,165  Antibacterial
0,101  0,004  Glutamate (mGluR4) agonist
0,100  0,004  Kainate receptor 5 antagonist
0,208  0,113  Spasmolytic
0,099  0,005  GABA B receptor antagonist
0,214  0,120  Cardioprotectant
0,108  0,014  Glutamate (mGluR1) antagonist
0,098  0,005  GHS receptor agonist
0,151  0,058  Neurotrophic factor
0,158  0,066  Insulin secretagoues
0,107  0,015  Antimetabolite
0,124  0,032  Alcohol dehydrogenase inhibitor
0,161  0,071  Eye irritation, high
0,109  0,019  Neutrophil collagenase inhibitor
0,091  0,002  GRP78 expression inhibitor
0,196  0,107  Antihypercholesterolemic
0,140  0,052  Alkylator
0,140  0,053  Histone deacetylase class III inhibitor
0,102  0,016  NMDA receptor glycine site agonist
0,090  0,004  Kainate receptor 4 antagonist
0,117  0,031  Metalloproteinase-2 inhibitor
0,198  0,114  Hypoglycemic
0,090  0,006  Prolactin release inhibitor
0,114  0,030  Ornithine decarboxylase inhibitor
0,104  0,021  Sirtuin 1 inhibitor
0,181  0,098  Antihypertriglyceridemic
0,090  0,007  VLA-4 antagonist
0,091  0,008  Somatostatin 1 antagonist
0,144  0,062  Psychosexual dysfunction treatment
0,086  0,004  Glutamate (mGluR8) agonist
0,086  0,003  Excitatory amino acid transporter 2 inhibitor
0,148  0,066  Ca2+/calmodulin-dependent kinase II delta inhibitor
0,156  0,074  Restenosis treatment
0,137  0,056  Aldehyde dehydrogenase inhibitor
0,135  0,053  Monophenol monooxygenase inhibitor
0,085  0,004  Kainate receptor 3 antagonist
0,143  0,062  Ca2+-transporting ATPase inhibitor
0,091  0,011  Complement C3a chemotactic receptor antagonist
0,086  0,006  Carbonic anhydrase I stimulant
0,118  0,038  Protein kinase C delta inhibitor
0,084  0,004  AMPA receptor agonist
0,110  0,031  Bile acid receptor antagonist
0,143  0,065  Bone formation stimulant
0,086  0,007  Integrin alpha4 antagonist
0,087  0,009  Somatostatin agonist
0,107  0,029  Phosphofructokinase-1 inhibitor
0,110  0,031  Glutamate receptor agonist
0,106  0,029  Opioid delta receptor antagonist
0,221  0,143  CTGF expression inhibitor
0,083  0,008  Somatostatin 2 antagonist
0,164  0,089  Antineoplastic (bone cancer)
0,078  0,004  Bombesin 1 receptor antagonist
0,169  0,095  Anesthetic general
0,228  0,156  Vasodilator, coronary
0,080  0,008  Somatostatin 5 antagonist
0,158  0,086  UGT2B10 substrate
0,086  0,015  Phosphorylase inhibitor
0,150  0,079  Protein-tyrosine phosphatase inhibitor
0,219  0,148  CYP3A4 inhibitor
0,104  0,034  Adrenaline agonist
0,154  0,084  Interleukin 6 antagonist
0,101  0,031  5 Hydroxytryptamine 1F antagonist
0,077  0,007  Immunoglobulin Fc receptor antagonist
0,074  0,005  Cholecystokinin agonist
0,144  0,075  Genotoxic
0,157  0,089  Antianginal
0,095  0,028  Sphingosine 1-phosphate receptor 4 agonist
0,077  0,010  Bombesin antagonist
0,157  0,090  3C-like protease (Human coronavirus) inhibitor
0,093  0,026  Glycine receptor agonist
0,077  0,010  Growth hormone release inhibitor
0,120  0,054  Mucolytic
0,106  0,039  Antidote, mercury
0,073  0,007  Somatostatin 5 agonist
0,097  0,031  Protein kinase B alpha inhibitor
0,070  0,004  Glutamate (mGluR8) antagonist
0,108  0,043  Opioid antagonist
0,219  0,154  GST M1-1 substrate
0,087  0,022  Ribonucleoside-diphosphate reductase inhibitor
0,150  0,086  Irritable Bowel syndrome treatment
0,082  0,018  MDM2 inhibitor
0,074  0,010  Thymidylate synthase inhibitor
0,156  0,093  Antipruritic, non-allergic
0,230  0,166  Immunosuppressant
0,120  0,057  GABA receptor agonist
0,067  0,004  Thyroid hormone agonist
0,167  0,104  Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor
0,086  0,024  Ribonucleotide reductase inhibitor
0,076  0,015  Aconitate hydratase inhibitor
0,093  0,033  NAT1 substrate
0,089  0,029  Antidote, organophosphates
0,150  0,090  Macular degeneration treatment
0,121  0,061  Antifungal (Pneumocystis)
0,192  0,133  Antiosteoporotic
0,122  0,063  Proteasome inhibitor
0,128  0,069  Cyclooxygenase 3 inhibitor
0,111  0,052  Carbonic anhydrase III inhibitor
0,094  0,035  Metalloproteinase-9 inhibitor
0,220  0,162  Sodium/bile acid cotransporter inhibitor
0,165  0,107  CYP2B6 inhibitor
0,081  0,024  Alcohol oxidase inhibitor
0,077  0,020  Bombesin 3 receptor antagonist
0,079  0,022  GP IIb/IIIa receptor antagonist
0,091  0,035  Opioid mu receptor antagonist
0,064  0,007  5 Hydroxytryptamine 2B agonist
0,137  0,082  Antiprotozoal (Coccidial)
0,066  0,012  Growth hormone secretagogue receptor antagonist
0,140  0,087  Acute respiratory distress syndrome (ARDS) treatment
0,058  0,005  Integrin beta7 antagonist
0,073  0,020  Neurotensin receptor antagonist
0,109  0,057  Urease inhibitor
0,071  0,019  5 Hydroxytryptamine 2 agonist
0,106  0,053  Creatine kinase inhibitor
0,182  0,130  RNA-directed DNA polymerase inhibitor
0,092  0,040  CYP2A6 inhibitor
0,129  0,078  Antifungal enhancer
0,085  0,034  Selectin antagonist
0,060  0,010  Arginase inhibitor
0,055  0,006  GHS receptor antagonist
0,181  0,131  Antioxidant
0,077  0,028  Protein kinase C iota inhibitor
0,069  0,020  Angiotensin-converting enzyme inhibitor
0,137  0,088  Acetylcholine M1 receptor antagonist
0,060  0,012  Somatostatin 4 agonist
0,154  0,106  Hepatoprotectant
0,058  0,010  Growth hormone releasing factor agonist
0,105  0,058  Factor V inhibitor
0,178  0,130  Antidiabetic symptomatic
0,111  0,063  Chelator
0,052  0,005  Integrin alpha4beta7 antagonist
0,124  0,077  Antihelmintic (Trematoda)
0,143  0,096  Cystic fibrosis treatment
0,102  0,055  Tourette's syndrome treatment
0,050  0,005  Cholecystokinin A agonist
0,075  0,029  Antidote, heavy metal
0,075  0,029  Biliverdin reductase inhibitor
0,091  0,046  Glutathione S-transferase inhibitor
0,074  0,029  Beta 3 adrenoreceptor antagonist
0,060  0,014  AICAR transformylase inhibitor
0,049  0,004  ICAM 1 antagonist
0,188  0,143  Amyotrophic lateral sclerosis treatment
0,170  0,126  Antiviral (HIV)
0,060  0,017  Melanocortin 1 antagonist
0,084  0,041  GABA aminotransferase inhibitor
0,091  0,049  Granulocyte macrophage colony stimulating factor agonist
0,117  0,074  Antiviral (Influenza B)
0,054  0,012  Prostacyclin antagonist
0,134  0,092  Sphingosine 1-phosphate receptor 5 antagonist
0,189  0,147  Antidiabetic (type 2)
0,052  0,010  Integrin alpha2 antagonist
0,049  0,008  Lysine carboxypeptidase inhibitor
0,060  0,019  Neurokinin 2 antagonist
0,148  0,108  Platelet adhesion inhibitor
0,050  0,009  Endothelial nitric-oxide synthase inhibitor
0,062  0,023  Opioid mu receptor agonist
0,082  0,042  Cathepsin G inhibitor
0,056  0,017  Leukotriene A4 hydrolase inhibitor
0,047  0,008  Somatostatin 4 antagonist
0,073  0,034  Uterine relaxant
0,045  0,007  Glutamate (mGluR3) agonist
0,097  0,059  Interleukin 12 antagonist
0,050  0,013  Fumarate hydratase inhibitor
0,040  0,003  Excitatory amino acid transporter 1 inhibitor
0,107  0,072  Protein-tyrosine phosphatase 1B inhibitor
0,040  0,004  Follicle-stimulating hormone antagonist
0,064  0,029  Matrix metalloproteinase (membrane-type) inhibitor
0,119  0,083  Antibacterial (Helicobacter pylori)
0,042  0,008  Somatostatin 3 antagonist
0,135  0,101  Interferon gamma antagonist
0,125  0,090  UGT2B15 substrate
0,040  0,006  Glutamate (mGluR1a) agonist
0,125  0,092  Farnesoid X receptor antagonist
0,041  0,009  Urotensin II agonist
0,152  0,120  Death-associated protein kinase 3 inhibitor
0,089  0,057  Tocolytic
0,045  0,014  VCAM-1 antagonist
0,109  0,078  Antiprotozoal (Babesia)
0,079  0,048  Protein kinase B gamma inhibitor
0,045  0,014  VCAM antagonist
0,064  0,033  Gonadotropin-releasing hormone receptor agonist
0,055  0,025  Melanocortin antagonist
0,040  0,010  NMDA 2D receptor antagonist
0,122  0,092  Lipid peroxidase inhibitor
0,097  0,068  Protease inhibitor
0,056  0,027  Metalloproteinase-3 inhibitor
0,072  0,043  Matrix metalloproteinase inhibitor
0,037  0,008  Growth hormone release promoting
0,052  0,022  Melanocortin 4 antagonist
0,130  0,101  UGT1A4 substrate
0,041  0,012  Carboxypeptidase B inhibitor
0,140  0,112  Hearing loss treatment
0,112  0,083  Antiprotozoal (Amoeba)
0,062  0,035  Botulinum neurotoxin type A inhibitor
0,114  0,087  Antismoking
0,064  0,037  Aminopeptidase microsomal inhibitor
0,073  0,046  Peroxisome proliferator-activated receptor gamma antagonist
0,065  0,038  Caspase 9 inhibitor
0,096  0,069  Glutamate (mGluR7) agonist
0,125  0,100  Chemopreventive
0,107  0,081  Menstruation disorders treatment
0,048  0,023  Histamine H2 receptor agonist
0,066  0,042  CDC25B inhibitor
0,045  0,020  Membrane dipeptidase inhibitor
0,055  0,031  Carbonic anhydrase II stimulant
0,076  0,052  Analgesic, opioid
0,188  0,165  Antineoplastic (multiple myeloma)
0,028  0,004  Integrin beta2 antagonist
0,028  0,005  Excitatory amino acid transporter 3 inhibitor
0,175  0,152  Antineoplastic (pancreatic cancer)
0,096  0,074  Mediator release inhibitor
0,096  0,074  Expectorant
0,041  0,020  Calcitonin receptor agonist
0,025  0,005  Thyroid hormone alpha agonist
0,062  0,041  Beta 2 adrenoreceptor agonist
0,131  0,111  Aldose reductase substrate
0,039  0,020  Opioid delta receptor agonist
0,044  0,024  Integrin alpha5beta1 antagonist
0,063  0,044  5 Hydroxytryptamine 3 agonist
0,090  0,071  Interleukin 1 beta converting enzyme inhibitor
0,050  0,031  Adenosine deaminase inhibitor
0,077  0,058  Interferon agonist
0,032  0,014  5 Hydroxytryptamine 6 agonist
0,030  0,012  Integrin alpha2beta1 antagonist
0,134  0,116  LIM domain kinase 1 inhibitor
0,025  0,008  Aminopeptidase A inhibitor
0,033  0,016  Endothelin receptor antagonist
0,027  0,010  Bombesin agonist
0,035  0,018  Melanocortin 3 antagonist
0,039  0,023  Integrin alpha1beta1 antagonist
0,068  0,052  Protein kinase C beta inhibitor
0,027  0,011  Follicle-stimulating hormone agonist
0,048  0,032  Glycine transporter 2 inhibitor
0,075  0,061  MAP kinase kinase 7 inhibitor
0,050  0,035  Lysophosphatidic acid 3 receptor antagonist
0,019  0,004  Glutamate (mGluR6) agonist
0,017  0,003  Folate transporter 1 inhibitor
0,123  0,108  Antidiabetic (type 1)
0,106  0,091  Amylase inhibitor
0,054  0,039  Protein kinase C eta inhibitor
0,054  0,040  Neuropeptide agonist
0,022  0,008  Somatostatin 3 agonist
0,045  0,031  Beta adrenoreceptor agonist
0,130  0,117  Muscular dystrophy treatment
0,050  0,037  Beta 2 adrenoreceptor antagonist
0,076  0,064  Protein kinase A inhibitor
0,043  0,031  Histamine H1 receptor agonist
0,054  0,042  5 Hydroxytryptamine 7 agonist
0,015  0,003  Excitatory amino acid transporter 4 inhibitor
0,022  0,010  Integrin alphaVbeta1 antagonist
0,070  0,059  S-adenosyl-L-methionine decarboxylase inhibitor
0,030  0,019  5 Hydroxytryptamine 1D agonist
0,051  0,039  Opioid agonist
0,062  0,050  Interferon inducer
0,154  0,143  Fibrosis treatment
0,039  0,028  Substance P antagonist
0,031  0,021  Dipeptidyl peptidase I inhibitor
0,018  0,007  Somatostatin 2 agonist
0,021  0,010  Bombesin 3 receptor agonist
0,068  0,058  Phospholipase D inhibitor
0,092  0,082  AMP-activated protein kinase stimulant
0,014  0,004  Thyroid hormone beta agonist
0,072  0,063  Narcotic antagonist
0,024  0,016  Growth hormone releasing factor antagonist
0,059  0,051  Histone deacetylase SIRT3 inhibitor
0,033  0,026  RNA-directed RNA polymerase inhibitor
0,063  0,056  Antihemophilic
0,052  0,045  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,080  0,074  Falcipain inhibitor
0,032  0,026  Sodium-dependent vitamin C transporter 2 inhibitor
0,044  0,038  Aminopeptidase N inhibitor
0,059  0,054  Protease 3C (Human rhinovirus) inhibitor
0,014  0,008  Integrin alphaLbeta2 antagonist
0,031  0,025  Sirtuin 2 inhibitor
0,057  0,052  5 Hydroxytryptamine 1D antagonist
0,072  0,067  Chymotrypsin inhibitor
0,050  0,044  Alpha-mannosidase inhibitor
0,032  0,027  Melatonin receptor 1A agonist
0,055  0,050  Glutamate (mGluR) agonist
0,033  0,028  Growth factor receptor-bound protein 2 antagonist
0,077  0,073  Falcipain 2 inhibitor
0,019  0,016  Integrin beta5 antagonist
0,094  0,091  5 Hydroxytryptamine 2B antagonist
0,021  0,019  Melanocortin 1 agonist
0,033  0,030  Histone deacetylase 7 inhibitor
0,040  0,039  Dihydrofolate reductase inhibitor
0,151  0,150  Cyclic AMP phosphodiesterase inhibitor
0,019  0,017  Melanocortin 3 agonist
0,059  0,057  Beta adrenoreceptor antagonist
0,114  0,112  Diuretic
0,028  0,027  HCV NS5B polymerase inhibitor
0,018  0,017  Neutral endopeptidase inhibitor
0,014  0,013  CXC chemokine 4 receptor agonist
0,061  0,060  Female sexual dysfunction treatment
0,078  0,078  NADH dehydrogenase inhibitor
0,021  0,021  NMDA receptor glycine site antagonist
0,081  0,081  Polo-like kinase-1 inhibitor
0,013  0,013  Carbonic anhydrase IV stimulant

